Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma

Journal of Pathology

Volumn 234, Issue 1, 2014, Pages 23-33

  Campos, Benito ^a   Gal, Zoltan ^a   Baader, Aline ^a   Schneider, Tilman ^a   Sliwinski, Christopher ^a   Gassel, Kristina ^a   Bageritz, Josephine ^b   Grabe, Niels ^a   Von Deimling, Andreas ^a   Beckhove, Philipp ^b   Mogler, Carolin ^a   Goidts, Violaine ^b   Unterberg, Andreas ^a   Eckstein, Volker ^a   Herold Mende, Christel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

self renewal; glioblastoma; label retention; quiescence

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL LINE; CANCER RESISTANCE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE; CELL CYCLE ASSAY; CELL RENEWAL; CELL SUBPOPULATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; COLONY FORMING CELL; CONTROLLED STUDY; DAUGHTER CELL; GENE EXPRESSION; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; MOUSE; MOUSE MODEL; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUIESCENCE; SELF RENEWAL; TUMOR CELL; TUMOR CELL CULTURE; TUMOR GROWTH; TUMOR RECURRENCE; ANIMAL; BRAIN TUMOR; CANCER STEM CELL; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODEL; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODELS, ANIMAL; GENE DOSAGE; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; MICE; NEOPLASM RECURRENCE, LOCAL; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84905913486     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4366     Document Type: Article

References (29)

1. Lee J, Kotliarova S, Kotliarov Y, et al., Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
2. Singh SK, Hawkins C, Clarke ID, et al., Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
3. Beier D, Wischhusen J, Dietmaier W, et al., CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol 2008; 18: 370-377.
4. Pallini R, Ricci-Vitiani L, Banna GL, et al., Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 2008; 14: 8205-8212.
5. Zeppernick F, Ahmadi R, Campos B, et al., Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008; 14: 123-129.
6. Ogden AT, Waziri AE, Lochhead RA, et al., Identification of A2B5 + CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 2008; 62: 505-514; discussion 514-515.
7. Son MJ, Woolard K, Nam D-H, et al., SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 2009; 4: 440-452.
8. Lathia JD, Gallagher J, Heddleston JM, et al., Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 2010; 6: 421-432.
9. Hirschmann-Jax C, Foster AE, Wulf GG, et al., A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004; 101: 14228-14233.
10. Rasper M, Schäfer A, Piontek G, et al., Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity. Neuro-oncology 2010; 12: 1024-1033.
11. Campos B, Herold-Mende CC,. Insight into the complex regulation of CD133 in glioma. Int J Cancer 2011; 128: 501-510.
12. Louis SA, Rietze RL, Deleyrolle L, et al., Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay. Stem Cells 2008; 26: 988-996.
13. Ernst A, Hofmann S, Ahmadi R, et al., Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res 2009; 15: 6541-6550.
14. Brennan CW, Verhaak RGW, McKenna A, et al., The somatic genomic landscape of glioblastoma. Cell 2013; 155: 462-477.
15. Campos B, Wan F, Farhadi M, et al., Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010; 16: 2715-2728.
16. Amente S, Lavadera ML, Palo GD, et al., SUMO-activating SAE1 transcription is positively regulated by Myc. Am J Cancer Res 2012; 2: 330-334.
17. Date DA, Jacob CJ, Bekier ME, et al., Borealin is repressed in response to p53/Rb signaling. Cell Biol Int 2007; 31: 1470-1481.
18. Bartholomeeusen K, Xiang Y, Fujinaga K, et al., Bromodomain and extra-terminal (BET) bromodomain inhibition activate transcription via transient release of positive transcription elongation factor b (P-TEFb) from 7SK small nuclear ribonucleoprotein. J Biol Chem 2012; 287: 36609-36616.
19. Wang J, He X, Luo Y, et al., A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem J 2006; 393: 489-501.
20. Orr SJ, Boutz DR, Wang R, et al., Proteomic and protein interaction network analysis of human T lymphocytes during cell-cycle entry. Mol Syst Biol 2012; 8: 573.
21. Ping Z, Lim R, Bashir T, et al., APC/C (Cdh1) controls the proteasome-mediated degradation of E2F3 during cell cycle exit. Cell Cycle 2012; 11: 1999-2005.
22. Sarvaiya PJ, Schwartz JR, Hernandez CP, et al., Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis. Am J Hematol 2012; 87: 969-976.
23. Laks DR, Masterman-Smith M, Visnyei K, et al., Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 2009; 27: 980-987.
24. Mascré G, Dekoninck S, Drogat B, et al., Distinct contribution of stem and progenitor cells to epidermal maintenance. Nature 2012; 489: 257-262.
25. Deleyrolle LP, Harding A, Cato K, et al., Evidence for label-retaining tumour-initiating cells in human glioblastoma. Brain 2011; 134: 1331-1343.
26. Richichi C, Brescia P, Alberizzi V, et al., Marker-independent method for isolating slow-dividing cancer stem cells in human glioblastoma. Neoplasia 2013; 15: 840-847.
27. Chen J, Li Y, Yu T-S, et al., A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522-526.
28. Xin H-W, Ambe CM, Hari DM, et al., Label-retaining liver cancer cells are relatively resistant to sorafenib. Gut 2013; 62: 1777-1786.
29. Xin H-W, Ambe CM, Ray S, et al., Wnt and the cancer niche: paracrine interactions with gastrointestinal cancer cells undergoing asymmetric cell division. J Cancer 2013; 4: 447-457.